Cartesian Therapeutics
RNAC
RNAC
46 hedge funds and large institutions have $124M invested in Cartesian Therapeutics in 2017 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 14 increasing their positions, 7 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
12% less capital invested
Capital invested by funds: $140M → $124M (-$16.7M)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Holders
46
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$3.09M | |
| 2 | +$2.98M | |
| 3 | +$2.96M | |
| 4 |
Millennium Management
New York
|
+$1.65M |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$944K |
Top Sellers
| 1 | -$1.65M | |
| 2 | -$1.37M | |
| 3 | -$573K | |
| 4 |
HC
Hillman Company
Pittsburgh,
Pennsylvania
|
-$290K |
| 5 |
JPMorgan Chase & Co
New York
|
-$226K |